{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:03:17Z","timestamp":1756425797954,"version":"3.44.0"},"reference-count":19,"publisher":"BMJ","issue":"3","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2022,2,22]]},"published-print":{"date-parts":[[2022,3]]},"abstract":"<jats:p>Hodgkin lymphoma (HL) survivors have an increased risk of developing subsequent treatment-related primary malignancies. In the last few decades, advances in knowledge, radiotherapy, chemotherapy and autologous stem cell transplantation have led to the transformation of lethal malignancy into highly curable malignancy, thereby improving outcomes. With prolonged survival, the risk of developing subsequent treatment-related late adverse effects, such as malignancies, steadily increases over time. Herein, we present the first case of a treatment-related second primary stage IV peripheral small cell lung carcinoma in a female HL survivor who was also diagnosed with right breast cancer 13 years after HL treatment and 1\u2009year before her lung cancer diagnosis.<\/jats:p>","DOI":"10.1136\/bcr-2022-249104","type":"journal-article","created":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T11:19:09Z","timestamp":1646824749000},"page":"e249104","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Treatment-related peripheral small cell lung carcinoma in a Hodgkin lymphoma survivor"],"prefix":"10.1136","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2545-5194","authenticated-orcid":false,"given":"Prathyusha","family":"Gudapati","sequence":"first","affiliation":[{"name":"Internal Medicine, UNC Health Southeastern, Lumberton, North Carolina, USA"},{"name":"Internal Medicine, Campbell University Jerry M Wallace School of Osteopathic Medicine, Lillington, North Carolina, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mouna","family":"Abouamara","sequence":"additional","affiliation":[{"name":"Medicine, Duke University School of Medicine, Durham, North Carolina, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2022,3,9]]},"reference":[{"key":"2025082801385723000_15.3.e249104.1","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s13045-019-0799-1","article-title":"Global, regional, and national burden of Hodgkin lymphoma from 1990 to 2017: estimates from the 2017 global burden of disease study","volume":"12","author":"Zhou","year":"2019","journal-title":"J Hematol Oncol"},{"key":"2025082801385723000_15.3.e249104.2","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.pathol.2019.09.005","article-title":"Hodgkin lymphoma: a review of pathological features and recent advances in pathogenesis","volume":"52","author":"Piris","year":"2020","journal-title":"Pathology"},{"unstructured":"Adult Hodgkin Lymphoma Treatment (PDQ\u00ae)\u2013health professional version [Internet]. National Cancer Institute, 2022. Available: https:\/\/www.cancer.gov\/types\/lymphoma\/hp\/adult-hodgkin-treatment-pdq#_36","key":"2025082801385723000_15.3.e249104.3"},{"doi-asserted-by":"publisher","key":"2025082801385723000_15.3.e249104.4","DOI":"10.1182\/blood-2013-10-532184"},{"unstructured":"Casciato DA , Territo MC . Hodgkins and Non-Hodgkins Lymphoma. In: Manual of clinical oncology. 7th ed. Philadelphia, PA: Wolters Kluwer\/Lippincott Williams & Wilkins Health, 2012: p. 520.","key":"2025082801385723000_15.3.e249104.5"},{"key":"2025082801385723000_15.3.e249104.6","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s12094-015-1342-7","article-title":"Lung cancer and other second neoplasms after treatment of Hodgkin lymphoma","volume":"18","author":"Almagro-Casado","year":"2016","journal-title":"Clin Transl Oncol"},{"doi-asserted-by":"publisher","key":"2025082801385723000_15.3.e249104.7","DOI":"10.1182\/blood-2002-02-0634"},{"key":"2025082801385723000_15.3.e249104.8","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1200\/JCO.2000.18.3.498","article-title":"Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: the relation to age at treatment","volume":"18","author":"Swerdlow","year":"2000","journal-title":"J Clin Oncol"},{"doi-asserted-by":"publisher","key":"2025082801385723000_15.3.e249104.9","DOI":"10.1200\/JCO.2002.09.038"},{"doi-asserted-by":"publisher","key":"2025082801385723000_15.3.e249104.10","DOI":"10.1093\/annonc\/mdr551"},{"doi-asserted-by":"publisher","key":"2025082801385723000_15.3.e249104.11","DOI":"10.1093\/jnci\/94.3.182"},{"key":"2025082801385723000_15.3.e249104.12","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1056\/NEJMoa064601","article-title":"Chemotherapy plus Involved-Field Radiation in Early-Stage Hodgkin\u2019s Disease","volume":"357","author":"Ferm\u00e9","year":"2007","journal-title":"N Engl J Med Overseas Ed"},{"doi-asserted-by":"publisher","key":"2025082801385723000_15.3.e249104.13","DOI":"10.1200\/JCO.2004.12.170"},{"doi-asserted-by":"publisher","key":"2025082801385723000_15.3.e249104.14","DOI":"10.1200\/JCO.2003.03.023"},{"doi-asserted-by":"publisher","key":"2025082801385723000_15.3.e249104.15","DOI":"10.1186\/1748-717X-2-13"},{"doi-asserted-by":"publisher","key":"2025082801385723000_15.3.e249104.16","DOI":"10.1002\/cncr.23081"},{"doi-asserted-by":"publisher","key":"2025082801385723000_15.3.e249104.17","DOI":"10.1056\/NEJM199211193272102"},{"key":"2025082801385723000_15.3.e249104.18","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1001\/jamaoncol.2017.4887","article-title":"Association of treatment for Hodgkin lymphoma with estrogen receptor status of subsequent breast cancers","volume":"4","author":"Withrow","year":"2018","journal-title":"JAMA Oncol"},{"doi-asserted-by":"publisher","key":"2025082801385723000_15.3.e249104.19","DOI":"10.1667\/0033-7587(2003)159[0161:LCATFH]2.0.CO;2"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2022-249104","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T08:39:02Z","timestamp":1756370342000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2022-249104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":19,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,3,9]]},"published-print":{"date-parts":[[2022,3]]}},"alternative-id":["10.1136\/bcr-2022-249104"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2022-249104","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2022,3]]}}}